CREDIT SUISSE AG/ - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q3 2014. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$35,151,000
+1417.7%
162,061
+707.7%
0.02%
+1700.0%
Q4 2020$2,316,000
+221.2%
20,064
+170.8%
0.00%
Q3 2020$721,000
+46.8%
7,410
+85.1%
0.00%
Q2 2020$491,000
-86.2%
4,003
-90.1%
0.00%
-100.0%
Q1 2020$3,549,000
+473.3%
40,543
+584.8%
0.00%
Q4 2019$619,000
-97.3%
5,920
-97.0%
0.00%
-100.0%
Q3 2019$23,009,000
+230.9%
200,027
+396.9%
0.02%
+216.7%
Q3 2018$6,954,000
+2809.6%
40,259
+2262.6%
0.01%
Q2 2018$239,000
-41.8%
1,704
-53.3%
0.00%
Q1 2018$411,000
-61.4%
3,650
-54.8%
0.00%
-100.0%
Q4 2017$1,066,000
-78.4%
8,077
-83.4%
0.00%
-80.0%
Q3 2017$4,933,000
-9.6%
48,608
-10.7%
0.01%0.0%
Q2 2017$5,455,000
-60.9%
54,408
-52.8%
0.01%
-61.5%
Q1 2017$13,954,000
-13.8%
115,384
-20.4%
0.01%
-18.8%
Q4 2016$16,196,000
+1216.7%
144,941
+1464.4%
0.02%
+1500.0%
Q3 2016$1,230,000
-21.0%
9,265
-45.5%
0.00%
-50.0%
Q2 2016$1,556,000
+634.0%
16,986
+477.4%
0.00%
Q1 2016$212,000
-84.1%
2,942
-84.7%
0.00%
-100.0%
Q4 2015$1,337,000
+382.7%
19,243
+535.7%
0.00%
Q3 2015$277,000
-79.8%
3,027
-72.8%
0.00%
-100.0%
Q2 2015$1,369,000
-30.5%
11,138
-48.4%
0.00%
-50.0%
Q1 2015$1,969,000
+2.6%
21,606
-23.8%
0.00%0.0%
Q4 2014$1,920,000
+318.3%
28,372
+399.9%
0.00%
Q3 2014$459,000
+16.8%
5,676
+55.0%
0.00%
Q2 2014$393,000
-64.8%
3,661
-80.5%
0.00%
-100.0%
Q1 2014$1,116,00018,8010.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders